FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Chikako Shimizu

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
Takashi Hojo; Kentaro Imi; Shigeru Imoto; Hirotsugu Isaka; Hiroki Ito; Takayuki Kinoshita; Chikako Shimizu; Noriaki Wada; Masashi Ando; Yasuhiro Fujiwara
Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: A randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy.
Mayu Yunokawa; Masashi Ando; Noriyuki Katsumata; Makoto Kodaira; Chikako Shimizu; Kenji Tamura; Harukaze Yamamoto; Kan Yonemori; Yasuhiro Fujiwara
A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer.
Akiko Kawano Nagatsuma; Shigehira Saji; Chikako Shimizu; Kokichi Sugano; Fumiaki Takahashi; Masahiro Takeuchi; Hitoshi Tsuda; Hirofumi Fujii; Takashi Hojo; Yasuhiro Fujiwara
Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese women.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Chikako Shimizu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Takashi Hojo; Kentaro Imi; Shigeru Imoto; Hirotsugu Isaka; Hiroki Ito; Takayuki Kinoshita; Chikako Shimizu; Noriaki Wada; Masashi Ando; Yasuhiro Fujiwara
Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: A randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy.
Breast (Edinburgh, Scotland) 2013;22(3):263-7.
2013: Mayu Yunokawa; Masashi Ando; Noriyuki Katsumata; Makoto Kodaira; Chikako Shimizu; Kenji Tamura; Harukaze Yamamoto; Kan Yonemori; Yasuhiro Fujiwara
A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer.
Cancer chemotherapy and pharmacology 2013;71(5):1369-74.
2013: Akiko Kawano Nagatsuma; Shigehira Saji; Chikako Shimizu; Kokichi Sugano; Fumiaki Takahashi; Masahiro Takeuchi; Hitoshi Tsuda; Hirofumi Fujii; Takashi Hojo; Yasuhiro Fujiwara
Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese women.
Breast cancer research and treatment 2013;138(3):941-50.
2013: Akiko Kawano; Takayuki Kinoshita; Chikako Shimizu; Hitoshi Tsuda; Hirofumi Fujii; Kenji Hashimoto; Yasuhiro Fujiwara
Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer.
Breast cancer (Tokyo, Japan) 2013;20(2):145-51.
2013: Yuko Tanabe; Kan Yonemori; Mayu Yunokawa; Masashi Ando; Kenichi Harano; Kenji Hashimoto; Akihiro Hirakawa; Noriyuki Katsumata; Takayuki Kinoshita; Chikako Shimizu; Kenji Tamura; Yasuhiro Fujiwara
Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer.
International journal of clinical oncology 2013;18(1):132-8.
2013: Emi Noguchi; Chikako Shimizu
[T-DM1 and pertuzumab: emerging anti-HER2 therapeutics].
Gan to kagaku ryoho. Cancer & chemotherapy 2013;40(1):10-4.
2012: Chikako Shimizu; Kenji Hashimoto; Akiko Nagatsuma
[Predictive factors for endocrine responsiveness in stage IV breast cancer].
Nihon rinsho. Japanese journal of clinical medicine 2012;70 Suppl 7():470-4.
2012: Kenichi Harano; Noriyuki Katsumata; Yuko Sasajima; Chikako Shimizu; Kenji Tamura; Hitoshi Tsuda; Kan Yonemori; Mayu Yunokawa; Masashi Ando; Yasuhiro Fujiwara
Primary yolk sac tumor of the omentum: a case report and literature review.
Case reports in oncology 2012;5(3):671-5.
2012: Yuki Kojima; Atsushi Makimoto; Chikako Shimizu; Kenji Tamura; Harukaze Yamamoto; Kan Yonemori; Mayu Yunokawa; Masashi Ando; Kenji Hashimoto; Ako Hosono; Makoto Kodaira; Yasuhiro Fujiwara
Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.
Cancer chemotherapy and pharmacology 2012;70(3):391-7.
2012: Mayu Yunokawa; Kan Yonemori; Teruhiko Yoshida; Masashi Ando; Yasuhiro Fujiwara; Yasufumi Katanasaka; Yuka Kitamura; Makoto Kodaira; Fumiaki Koizumi; Kenkichi Masutomi; Naoko Okamoto; Chikako Shimizu; Kenji Tamura
Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells.
Cancer science 2012;103(9):1665-71.
2012: Yuki Kojima; Atsushi Makimoto; Chikako Shimizu; Kenji Tamura; Kan Yonemori; Mayu Yunokawa; Kenji Hashimoto; Akihiro Hirakawa; Ako Hosono; Noriyuki Katsumata; Makoto Kodaira; Masashi Ando; Yasuhiro Fujiwara
Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy.
Journal of cancer research and clinical oncology 2012;138(7):1249-57.
2012: Kenji Hashimoto; Taizo Hirata; Noriyuki Katsumata; Motokiyo Komiyama; Masahiro Koseki; Tsutomu Kouno; Tohru Nakagawa; Hiroyuki Nakanishi; Chikako Shimizu; Masahiro Takeuchi; Kenji Tamura; Kan Yonemori; Mayu Yunokawa; Masashi Ando; Hiroyuki Fujimoto; Yasuhiro Fujiwara
The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors.
Urologic oncology 2012;30(3):319-24.
2012: Makiko Ono; Tatsuhiro Shibata; Chikako Shimizu; Yuichi Takiguchi; Kenji Tamura; Hideki Tanzawa; Hitoshi Tsuda; Harukaze Yamamoto; Sohei Yamamoto; Kan Yonemori; Masashi Ando; Taizo Hirata; Noriyuki Katsumata; Takayuki Kinoshita; Yasuhiro Fujiwara
Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer.
Breast cancer research and treatment 2012;132(3):793-805.
2012: Akiko Kubo; Koji Murakoshi; Yasuaki Ryushima; Mari Sawada; Chikako Shimizu; Masashi Ando; Yasuhiro Fujiwara; Tomoyasu Kato; Takayuki Kinoshita; Keiichi Koido; Nobuaki Yokote; Hiroshi Yamamoto
[Survey on oncologists-provided information on treatment-related infertility to breast cancer patients].
Gan to kagaku ryoho. Cancer & chemotherapy 2012;39(3):399-403.
2012: Masashi Ando; Kenji Hashimoto; Taizo Hirata; Noriyuki Katsumata; Chikako Shimizu; Kenji Tamura; Harukaze Yamamoto; Kan Yonemori; Mayu Yunokawa; Yasuhiro Fujiwara
Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer.
Cancer chemotherapy and pharmacology 2012;69(2):457-65.
2012: Kan Yonemori; Mayu Yunokawa; Masashi Ando; Akihiro Hirakawa; Taizo Hirata; Chikako Shimizu; Kenji Tamura; Yasuhiro Fujiwara
Content analysis of oncology-related pharmaceutical advertising in a peer-reviewed medical journal.
PloS one 2012;7(8):e44393.
2012: Hirokazu Shoji; Kenji Tamura; Kan Yonemori; Mayu Yunokawa; Masashi Ando; Kenji Hashimoto; Makoto Kodaira; Chikako Shimizu; Yasuhiro Fujiwara
Hematologic safety of breast cancer chemotherapies in patients with hepatitis B or C virus infection.
Oncology 2012;82(4):228-33.
2012: Kenji Hashimoto; Akihiko Osaki; Shigehira Saji; Takashi Shigekawa; Chikako Shimizu; Hitoshi Tsuda; Kenjiro Aogi
Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
Oncology 2012;82(3):168-74.
2011: Kenji Hashimoto; Akihiro Hirakawa; Taizo Hirata; Noriyuki Katsumata; Chikako Shimizu; Kenji Tamura; Harukaze Yamamoto; Kan Yonemori; Masashi Ando; Yasuhiro Fujiwara
Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma.
European journal of obstetrics, gynecology, and reproductive biology 2011;159(2):394-8.
2011: Makiko Ono; Chikako Shimizu; Kenji Tamura; Harukaze Yamamoto; Kan Yonemori; Masashi Ando; Taizo Hirata; Noriyuki Katsumata; Yasuhiro Fujiwara
Second-line chemotherapy in patients with primary unknown cancer.
Journal of cancer research and clinical oncology 2011;137(8):1185-91.
2011: Kan Yonemori; Akihiro Hirakawa; Masashi Ando; Taizo Hirata; Mayu Yunokawa; Chikako Shimizu; Noriyuki Katsumata; Kenji Tamura; Yasuhiro Fujiwara
The notorious "drug lag" for oncology drugs in Japan.
Investigational new drugs 2011;29(4):706-12.
2011: Maki Tanioka; Kan Yonemori; Masashi Ando; Noriyuki Katsumata; Tsutomu Kouno; Chikako Shimizu; Kenji Tamura; Yasuhiro Fujiwara
Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy.
Cancer chemotherapy and pharmacology 2011;68(2):337-42.
2011: Takahiro Hasebe; Takashi Hojo; Motoki Iwasaki; Takayuki Kinoshita; Yuko Sasajima; Tatsuhiro Shibata; Chikako Shimizu; Sadako Akashi-Tanaka; Masashi Andoh; Yasuhiro Fujiwara; Hitoshi Tsuda
Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapy.
Human pathology 2011;42(7):998-1006.
2011: Kenji Hashimoto; Kan Yonemori; Chikako Shimizu; Akihiro Hirakawa; Harukaze Yamamoto; Makiko Ono; Taizo Hirata; Tsutomu Kouno; Kenji Tamura; Noriyuki Katsumata; Masashi Ando; Yasuhiro Fujiwara
A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer.
Medical oncology (Northwood, London, England) 2011;28(2):434-40.
2010: Takahiro Hasebe; Nobuko Tamura; Motoki Iwasaki; Nao Okada; Sadako Akashi-Tanaka; Takashi Hojo; Chikako Shimizu; Masashi Adachi; Yasuhiro Fujiwara; Tatsuhiro Shibata; Yuko Sasajima; Histoshi Tsuda; Takayuki Kinoshita
Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(4):581-92.
2010: Kan Yonemori; Koji Tsuta; Chikako Shimizu; Yutaka Hatanaka; Akihiro Hirakawa; Makiko Ono; Tsutomu Kouno; Noriyuki Katsumata; Masashi Ando; Kenji Tamura; Tadashi Hasegawa; Takayuki Kinoshita; Yasuhiro Fujiwara
Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy.
Journal of surgical oncology 2010;101(3):222-7.
2010: Takahiro Hasebe; Nobuko Tamura; Nao Okada; Takashi Hojo; Sadako Akashi-Tanaka; Chikako Shimizu; Histoshi Tsuda; Tatsuhiro Shibata; Yuko Sasajima; Motoki Iwasaki; Takayuki Kinoshita
p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapy.
Human pathology 2010;41(2):262-70.
2010: Kan Yonemori; Koji Tsuta; Makiko Ono; Chikako Shimizu; Akihiro Hirakawa; Tadashi Hasegawa; Yutaka Hatanaka; Yoshitaka Narita; Soichiro Shibui; Yasuhiro Fujiwara
Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer.
Cancer 2010;116(2):302-8.
2010: Kan Yonemori; Tsutomu Kouno; Masashi Ando; Akihiro Hirakawa; Harukaze Yamamoto; Makiko Ono; Taizo Hirata; Chikako Shimizu; Kenji Tamura; Noriyuki Katsumata; Yasuhiro Fujiwara
Influence of suboptimal treatment in patients with mediastinal primary nonseminomatous germ cell tumors.
Oncology 2010;78(1):34-9.
2009: Chikako Shimizu; Norikazu Masuda; Kenichi Yoshimura; Hitoshi Tsuda; Masayuki Mano; Masashi Ando; Kenji Tamura; Yasuhiro Fujiwara
Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancer.
Japanese journal of clinical oncology 2009;39(8):484-90.
2009: Kenji Hashimoto; Kan Yonemori; Noriyuki Katsumata; Marika Hotchi; Tsutomu Kouno; Chikako Shimizu; Kenji Tamura; Masashi Ando; Masahiro Takeuchi; Yasuhiro Fujiwara
Factors that affect the duration of the interval between the completion of palliative chemotherapy and death.
The oncologist 2009;14(7):752-9.
2009: Satoru Iwasa; Masashi Ando; Makiko Ono; Taizo Hirata; Mayu Yunokawa; Eriko Nakano; Kan Yonemori; Tsutomu Kouno; Chikako Shimizu; Kenji Tamura; Noriyuki Katsumata; Yasuhiro Fujiwara
Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.
Japanese journal of clinical oncology 2009;39(7):456-9.
2009: Ayaka Iura; Noriyuki Katsumata; Tsutomu Kouno; Chikako Shimizu; Masashi Ando; Yasuhiro Fujiwara
Outpatient management of low-risk febrile patients on paclitaxel and carboplatin for ovarian cancer.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2009;105(3):261-2.
2009: Shin Nishio; Noriyuki Katsumata; Koji Matsumoto; Hiroshi Tanabe; Kan Yonemori; Tsutomu Kouno; Chikako Shimizu; Masashi Ando; Toshiharu Kamura; Takahiro Kasamatsu; Yasuhiro Fujiwara
Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.
Journal of cancer research and clinical oncology 2009;135(4):551-7.
2009: Makiko Ono; Masashi Ando; Mayu Yunokawa; Eriko Nakano; Kan Yonemori; Koji Matsumoto; Tsutomu Kouno; Chikako Shimizu; Kenji Tamura; Noriyuki Katsumata; Yasuhiro Fujiwara
Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer.
International journal of clinical oncology 2009;14(1):48-52.
2009: Kan Yonemori; Masashi Ando; Mayu Yunokawa; T Hirata; Tsutomu Kouno; Chikako Shimizu; K Tamura; Noriyuki Katsumata; A Hirakawa; Koji Matsumoto; Yasuhiro Yamanaka; H Arioka; Yasuhiro Fujiwara
Irinotecan plus carboplatin for patients with carcinoma of unknown primary site.
British journal of cancer 2009;100(1):50-5.
2009: Kan Yonemori; Koji Tsuta; Chikako Shimizu; Yutaka Hatanaka; Kaoru Hashizume; Makiko Ono; Tsutomu Kouno; Masashi Ando; Kenji Tamura; Noriyuki Katsumata; Tadashi Hasegawa; Takayuki Kinoshita; Yasuhiro Fujiwara
Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy.
Medical oncology (Northwood, London, England) 2009;26(3):344-9.
2008: Kan Yonemori; Koji Tsuta; Chikako Shimizu; Yutaka Hatanaka; Kaoru Hashizume; Makiko Ono; Yukihiro Nakanishi; Tadashi Hasegawa; Yasuji Miyakita; Yoshitaka Narita; Soichiro Shibui; Yasuhiro Fujiwara
Immunohistochemical profiles of brain metastases from breast cancer.
Journal of neuro-oncology 2008;90(2):223-8.
2008: Kan Yonemori; Noriyuki Katsumata; Ayako Noda; Hajime Uno; Mayu Yunokawa; Eriko Nakano; Tsutomu Kouno; Chikako Shimizu; Masashi Ando; Kenji Tamura; Masahiro Takeuchi; Yasuhiro Fujiwara
Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer.
Journal of cancer research and clinical oncology 2008;134(11):1199-206.
2008: Makiko Ono; Takashi Watanabe; Chikako Shimizu; Nobuhiro Hiramoto; Yasushi Goto; Kan Yonemori; Tsutomu Kouno; Masashi Ando; Kenji Tamura; Noriyuki Katsumata; Yasuhiro Fujiwara
Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer.
Japanese journal of clinical oncology 2008;38(8):567-70.
2008: Shin Nishio; Noriyuki Katsumata; Koji Matsumoto; Hiroshi Tanabe; Kan Yonemori; Tsutomu Kohno; Chikako Shimizu; Masashi Ando; Takahiro Kasamatsu; Yasuhiro Fujiwara
Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma.
Oncology reports 2008;19(2):497-503.
2008: Chikako Shimizu; Yasuhiro Fujiwara
Personalized systemic treatment for breast cancer patients: is it a reality?
Breast cancer (Tokyo, Japan) 2008;15(2):141-4.
2007: Tsutomu Kouno; Masashi Ando; Kan Yonemori; Koji Matsumoto; Chikako Shimizu; Noriyuki Katsumata; Motokiyo Komiyama; Eijiro Okajima; Naoki Matsuoka; Hiroyuki Fujimoto; Yasuhiro Fujiwara
Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
European urology 2007;52(4):1115-22.
2007: Kan Yonemori; Noriyuki Katsumata; Masayuki Kaneko; Hajime Uno; Koji Matsumoto; Tsutomu Kouno; Chikako Shimizu; Masashi Ando; Masahiro Takeuchi; Yasuhiro Fujiwara
Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy.
Breast cancer research and treatment 2007;103(3):313-8.
2007: Toshiro Mizuno; Noriyuki Katsumata; Hirofumi Mukai; Chikako Shimizu; Masashi Ando; Toru Watanabe
The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(3):287-91.
2006: Satomi Yakushiji; Masashi Ando; Kan Yonemori; Tsutomu Kohno; Chikako Shimizu; Noriyuki Katsumata; Yasuhiro Fujiwara
Cancer of unknown primary site: review of consecutive cases at the National Cancer Center Hospital of Japan.
International journal of clinical oncology 2006;11(6):421-5.
2006: Shin Nishio; Noriyuki Katsumata; Hiroshi Tanabe; Koji Matsumoto; Kan Yonemori; Tsutomu Kouno; Chikako Shimizu; Masashi Ando; Yasuhiro Fujiwara
[A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33(11):1589-93.
2006: Kan Yonemori; Masashi Ando; Taro Shibata; Noriyuki Katsumata; Koji Matsumoto; Yasuhiro Yamanaka; Tsutomu Kouno; Chikako Shimizu; Yasuhiro Fujiwara
Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy.
Journal of cancer research and clinical oncology 2006;132(10):635-42.
2006: Chikako Shimizu; Yasuhiro Fujiwara
[Pharmacogenomics in chemotherapy and drug development for breast cancer].
Nihon rinsho. Japanese journal of clinical medicine 2006;64(3):424-31.
2006: Koji Matsumoto; Noriyuki Katsumata; Yasuhiro Yamanaka; Kan Yonemori; Tsutomu Kohno; Chikako Shimizu; Masashi Andoh; Yasuhiro Fujiwara
The safety and efficacy of the weekly dosing of irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer.
Gynecologic oncology 2006;100(2):412-6.
2006: Kan Yonemori; Tadashi Hasegawa; Chikako Shimizu; Taro Shibata; Koji Matsumoto; Tsutomu Kouno; Masashi Ando; Noriyuki Katsumata; Yasuhiro Fujiwara
Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.
Pathology, research and practice 2006;202(10):705-12.
2005: Kan Yonemori; Noriyuki Katsumata; Hajime Uno; Koji Matsumoto; Tsutomu Kouno; Shinya Tokunaga; Yasuhiro Yamanaka; Chikako Shimizu; Masashi Ando; Masahiro Takeuchi; Yasuhiro Fujiwara
Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer.
Breast cancer research and treatment 2005;89(3):237-41.
2004: Chikako Shimizu; Tadashi Hasegawa; Yoichi Tani; Fumiaki Takahashi; Masahiro Takeuchi; Toru Watanabe; Masashi Ando; Noriyuki Katsumata; Yasuhiro Fujiwara
Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis.
Human pathology 2004;35(12):1537-42.
2002: Toru Watanabe; Noriyuki Katsumata; Masashi Ando; Hirofumi Mukai; Chikako Shimizu; Ryo Kitagawa; Nagahiro George Saijo
[Genetic testing for effective Herceptin therapy].
Nihon rinsho. Japanese journal of clinical medicine 2002;60(3):603-11.
2000: Toru Watanabe; Chikako Shimizu; Noriyuki Katsumata; Nagahiro Saijo
[Trastuzumab for treatment of advanced breast cancers].
Nihon rinsho. Japanese journal of clinical medicine 2000;58 Suppl():340-4.